12-11031280-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_176885.2(TAS2R31):āc.56T>Cā(p.Ile19Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,613,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_176885.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS2R31 | NM_176885.2 | c.56T>C | p.Ile19Thr | missense_variant | 1/1 | ENST00000390675.2 | NP_795366.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R31 | ENST00000390675.2 | c.56T>C | p.Ile19Thr | missense_variant | 1/1 | 6 | NM_176885.2 | ENSP00000375093.2 | ||
ENSG00000275778 | ENST00000703543.1 | c.-126+15740T>C | intron_variant | ENSP00000515364.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000401 AC: 10AN: 249258Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135256
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461708Hom.: 0 Cov.: 43 AF XY: 0.0000138 AC XY: 10AN XY: 727146
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 28, 2023 | The c.56T>C (p.I19T) alteration is located in exon 1 (coding exon 1) of the TAS2R31 gene. This alteration results from a T to C substitution at nucleotide position 56, causing the isoleucine (I) at amino acid position 19 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at